1
Bos, W.H., van Tubergen, A., Vonkeman, H.E.
Veröffentlicht in: Bos , W H , van Tubergen , A & Vonkeman , H E 2021 , ' Telemedicine for patients with rheumatic and musculoskeletal diseases during the COVID-19 pandemic; a positive experience in the Netherlands ' , Rheumatology International , vol. 41 , no. 3 , pp. 565-573 . https://doi.org/10.1007/s00296-020-04771-6;
2021
Veröffentlicht in: Bos , W H , van Tubergen , A & Vonkeman , H E 2021 , ' Telemedicine for patients with rheumatic and musculoskeletal diseases during the COVID-19 pandemic; a positive experience in the Netherlands ' , Rheumatology International , vol. 41 , no. 3 , pp. 565-573 . https://doi.org/10.1007/s00296-020-04771-6;
2021
2
3
4
5
6
7
Geeven, I.P.A.C., Jessurun, N.T., Wasylewicz, A.T.M., Drent, M., Spuls, P.I., Hoentjen, F., van Puijenbroek, E.P., Vonkeman, H.E., Grootens, K.P., van Doorn, M.B.A., van den Bemt, B.J.F., Bekkers, C.L.
Veröffentlicht in: Geeven , I P A C , Jessurun , N T , Wasylewicz , A T M , Drent , M , Spuls , P I , Hoentjen , F , van Puijenbroek , E P , Vonkeman , H E , Grootens , K P , van Doorn , M B A , van den Bemt , B J F & Bekkers , C L 2022 , ' Barriers and facilitators for systematically registering adverse drug reactions in electronic health records: a qualitative study with Dutch healthcare professionals ' , Expert opinion on drug safety , vol. 21 , no. 5 , pp. 699-706 . https://doi.org/10.1080/14740338.2022.2020756;
2022
Veröffentlicht in: Geeven , I P A C , Jessurun , N T , Wasylewicz , A T M , Drent , M , Spuls , P I , Hoentjen , F , van Puijenbroek , E P , Vonkeman , H E , Grootens , K P , van Doorn , M B A , van den Bemt , B J F & Bekkers , C L 2022 , ' Barriers and facilitators for systematically registering adverse drug reactions in electronic health records: a qualitative study with Dutch healthcare professionals ' , Expert opinion on drug safety , vol. 21 , no. 5 , pp. 699-706 . https://doi.org/10.1080/14740338.2022.2020756;
2022